What Drives a Higher EBITDA Valuation for Large Dental Practices in 2026

This article is written for owners of large dental practices, multi-location groups, and specialty platforms who are preparing for an IDSO partnership—and want to understand how to maximize their EBITDA valuation for a large dental practice. If your practice is already being evaluated as a business (not just a clinical operation), this will help you see what sophisticated partners—and LPS—look for in 2026.

As IDSO partnerships continue to expand and competition for high-quality practices intensifies, the gap between average and top-tier valuations has widened. The best practices are achieving premium EBITDA multiples, while stagnant or inefficient practices are being discounted.
Understanding what drives that difference is critical—because small operational improvements can translate into millions in additional enterprise value when structured properly through LPS.

In This Guide

What EBITDA Valuation Really Means in 2026
The Core Drivers of Higher EBITDA Multiples
Operational Factors That Increase Practice Value
Strategic Positioning: Why Timing and Buyer Fit Matter
The “Platform Effect” in Large Practice Valuations
Key Metrics That IDSOs Prioritize
FAQs

What EBITDA Valuation Really Means in 2026

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) represents the true cash flow of your practice after normalizing for owner compensation, discretionary expenses, and one-time costs. In other words, it reflects what a sophisticated partner sees as the real earning power of your business—not just what shows up on a tax return.

In an IDSO partnership, your practice is valued based on a multiple of EBITDA—not a percentage of collections. This distinction is critical. Collections tell you how busy the practice is; EBITDA tells you how profitable, efficient, and scalable it is.

For a more comprehensive explanation of how EBITDA is calculated, how valuation multiples work, and what determines a practice’s overall worth, explore our guide to understanding EBITDA valuation for large dental practices.

For large practices, this shift is significant:

• Smaller practices may still be evaluated on collections or simple rules of thumb
• Larger practices are evaluated like scalable healthcare businesses
• The higher your EBITDA quality, predictability, and growth, the higher your multiple

But in 2026, it’s not just about the number—it’s about the quality of that EBITDA.

What “Quality of EBITDA” Actually Means

Not all earnings are valued equally. IDSOs and LPS carefully evaluate:

• Sustainability – Is your EBITDA consistent year over year, or volatile?
• Source of production – Is revenue driven by a single doctor or a team?
• Adjustments (add-backs) – Are expenses truly non-recurring, or inflated?
• Operational efficiency – Are margins strong because of systems—or short-term cuts?

For example, a $1M EBITDA practice with strong associate coverage, clean financials, and steady growth may be valued significantly higher than a $1M EBITDA practice that relies entirely on the owner and has inconsistent performance.

The Shift from “Income” to “Enterprise Value”

This evolution marks a fundamental mindset change for practice owners. Instead of asking: “How much do I make each year?”

The better question becomes: “What is my business worth as a scalable platform?”

That shift is where substantial value is created.

EBITDA Multiples in Today’s Market

Exceptional practices can achieve 6x–12x EBITDA or more, depending on:

• Size and scale of the organization
• Growth rate and future expansion potential
• Competitive tension among IDSO partners
• Structure of the partnership (including equity rollover)

LPS plays a key role in this process by not only calculating EBITDA accurately, but also positioning your practice so that multiple qualified partners compete for it—which is often what drives valuations to the upper end of the range.

Ultimately, EBITDA valuation in 2026 is not just a formula—it’s a reflection of how well your practice is built to grow, scale, and perform within a larger platform.

The Core Drivers of Higher EBITDA Multiples

Not all EBITDA is valued equally. In 2026, IDSOs and LPS focus heavily on quality of earnings, not just size.

What Increases vs. Decreases EBITDA Valuation

Practices with strong growth trajectories and scalable systems consistently command premium valuations.

Operational Factors That Increase Practice Value

Beyond headline revenue and EBITDA, sophisticated partners in 2026 look closely at how your practice actually operates. The underlying systems, structure, and consistency of performance often determine whether your EBITDA is viewed as average or premium.

1. Provider Leverage (Associate Model)

Practices that are not dependent on a single doctor are significantly more valuable—not just in theory, but in how partners underwrite risk and future growth.

• Reduces key-person risk – If production is concentrated in one provider, the entire valuation becomes fragile. A diversified provider base creates stability.
• Increases scalability – Associate-driven models allow for expansion without requiring the owner to produce more clinically.
• Improves EBITDA stability – Revenue becomes more predictable when it’s generated across multiple providers with consistent schedules and systems.

From a valuation standpoint, this is one of the clearest dividing lines between a “practice” and a platform-ready business. LPS often sees significant valuation gaps between owner-centric and team-driven models—even at similar revenue levels. As outlined in this article on top value drivers for dental practices, practices with strong provider leverage consistently outperform in valuation outcomes.

2. Growth Rate

Growth is one of the most powerful—and most rewarded—valuation drivers.

• Practices growing ~20% annually have historically achieved top-tier multiples
• Even modest, consistent growth (5–10%) is viewed more favorably than flat performance

Why? Because growth signals future earnings potential, which is what partners are ultimately investing in.

A $5M practice growing at 15% annually may be valued higher than a $7M practice with no growth, simply because the trajectory is stronger. Growth demonstrates that your systems, marketing, patient flow, and provider model are all working together effectively.

For a deeper breakdown of how growth impacts valuation multiples, this guide provides additional context.

3. Payer Mix & Procedure Mix

Not all revenue is created equal. The composition of your revenue plays a major role in how your EBITDA is valued.

Higher-value practices typically have:

• Strong fee-for-service or optimized PPO mix – Greater control over pricing and margins
• Specialty or high-margin procedures – Implants, ortho, surgery, and other advanced services increase profitability per patient
• Efficient case acceptance systems – Strong treatment presentation and financing processes that convert diagnosed care into production

A diversified and optimized mix signals both resilience and upside, which directly impacts how partners assess long-term value.

4. Margin Discipline

EBITDA margins are a core benchmark—and a reflection of operational excellence.

• Strong practices often operate in the 15–30% EBITDA margin range
• Margins are evaluated alongside growth and sustainability, not in isolation

However, it’s not just about cutting costs. Sophisticated partners—and LPS—look for healthy, sustainable margins driven by:

• Efficient staffing models
• Strong scheduling and capacity utilization
• Controlled supply and lab costs
• Effective leadership and systems

Overly aggressive cost-cutting can actually hurt valuation if it compromises growth or patient experience. The goal is balanced, repeatable profitability.

For practice owners preparing for an IDSO partnership, identifying these operational improvements is only the first step. Implementing the right changes before entering the market can help strengthen profitability and position the practice for a more favorable valuation. Explore our strategies to improve EBITDA valuation for large dental practices to learn how to prepare your practice for a potential partnership.

Strategic Positioning: Why Timing and Buyer Fit Matter

In 2026, valuation is not just about your practice—it’s about who wants your practice, and when.

Even highly profitable practices can see vastly different outcomes depending on how they are positioned in the market. This is where LPS plays a critical role—creating a structured, competitive process that aligns your practice with the right IDSO partners at the right moment.

This often leads to meaningful valuation premiums because:

• Over 1,000+ IDSOs are actively seeking partnerships
• Each group has a different strategy, geography, and clinical focus
• Some are aggressively expanding in specific regions or specialties

When your practice aligns with a partner’s exact growth thesis, it becomes strategically valuable—not just financially attractive.

That “perfect fit” can increase value by 20–50% or more, especially when multiple qualified partners are competing simultaneously.

For additional insight into how IDSO alignment impacts outcomes, this article breaks down the strategic benefits of the right partnership structure.

Timing also matters. Market conditions, interest rates, fund cycles, and regional expansion priorities all influence how aggressively partners pursue opportunities at any given moment.

Ultimately, timing and positioning are often the hidden drivers of valuation—and the difference between an average outcome and an exceptional one.

The “Platform Effect” in Large Practice Valuations

Larger practices benefit from what can be called the platform effect:

• Multi-location or multi-specialty groups attract more interest
• IDSOs can scale efficiencies across locations
• Larger EBITDA bases justify higher multiples

In some cases, LPS has structured partnerships where aligned practices (e.g., pediatric, ortho, OMS) create a regional growth engine, increasing both immediate and long-term value.

This is why size—and structure—matter more than ever.

Key Metrics IDSOs Prioritize

When evaluating EBITDA valuation for a large dental practice, IDSOs focus on:

• Trailing 12-month EBITDA (normalized)
• Year-over-year growth rate
• Provider mix and scalability
• Patient retention and hygiene recall
• Geographic desirability
• Doctor’s long-term commitment

Importantly, practices with doctors committed to staying and growing the business tend to achieve the highest valuations and long-term upside.

Final Thoughts

The EBITDA valuation of a large dental practice in 2026 is driven by far more than financials—it’s a combination of growth, structure, scalability, and strategic positioning.

LPS specializes in identifying these value drivers, aligning your practice with the right IDSO partners, and creating competitive processes that maximize both immediate value and long-term equity upside.

If you want to better understand where your practice stands today, start by exploring this guide on dental practice valuation fundamentals.
Or, connect directly with LPS to receive a confidential, no-obligation valuation and strategic roadmap tailored to your practice.

FAQs

1. What is considered a strong EBITDA for a large dental practice? A strong EBITDA depends on size, but high-performing practices typically show strong margins and consistent growth, not just high revenue.

2. How much does growth impact valuation? Significantly. Growth is often one of the top drivers of premium EBITDA multiples.

3. Does size matter in EBITDA valuation? Yes. Larger practices with multiple providers and locations typically command higher multiples.

4. Is EBITDA more important than collections? For large practices, yes. EBITDA is the primary valuation metric in IDSO partnerships.

5. Can I increase my valuation before partnering? Absolutely. Improvements in operations, growth, and structure can materially increase value in a short time frame.

6. Why do similar practices receive very different valuations? Because valuation depends on growth, structure, timing, and buyer demand—not just revenue.